Repaglinide: uses, dosing, side effects & brands
Repaglinide is a medicine sold in the U.S. under 2 brand and generic names. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Tablet
- Sold as
- 2 products — Prandin and Repaglinide
- Prescription?
- Prescription only
- Generic available?
- Yes
- What the pharmacy pays
- about $3 for a 30-count supply — not your price
Every repaglinide product we track (2)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | Not yet rated | Prescription | Tablet | Generic | $3 | View → | |
| 2 | Not yet rated | Prescription | Tablet | Generic | $3 | View → |
What repaglinide pills look like
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
Combination products containing repaglinide
A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.
How long repaglinide keeps
No repaglinide label we read sets a separate limit for after opening, but they do specify how it must be stored — and the stability behind any date assumes those conditions.
Repaglinide and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for repaglinide: levels in milk, effects in breastfed infants, and the drugs it would consider insteadNo information is available on the use of repaglinide during breastfeeding. Repaglinide is a weak acid that is over 98% protein bound, so it is unlikely to pass into breastmilk in clinically important amounts. Monitor breastfed infants for signs of hypoglycemia such as jitteriness, excessive sleepiness, poor feeding, seizures cyanosis, apnea, or hypothermia. If there is concern, monitoring of the breastfed infant's blood glucose is advisable during maternal therapy with repaglinide. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
National Institute of Child Health and Human Development, record revised May 15, 2026. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about repaglinide
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 8,106 reports naming repaglinide, and the FDA flagged 91% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hypoglycaemia883 reports
- acute kidney injury574 reports
- diarrhoea422 reports
- lactic acidosis377 reports
- nausea318 reports
- dyspnoea309 reports
- blood glucose increased298 reports
- asthenia282 reports
Read these as a signal, not a rate. A report does not mean repaglinide caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved August 26, 2026.
Related calculators
Frequently asked questions
Can you take repaglinide with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run repaglinide against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What brand names is repaglinide sold under?
We track 2 repaglinide-containing products in the U.S.: Prandin and Repaglinide. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.
What forms does repaglinide come in?
Across the brands we track, repaglinide is currently marketed as tablet, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic repaglinide?
Yes. Our catalog lists 1 generic repaglinide product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.
Cite this page
- APA
- pharmaranks. (2026, July 24). Repaglinide: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/repaglinide
- MLA
- “Repaglinide: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/repaglinide.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for repaglinide on DailyMed (NIH) ↗.